A Clinical Study to Evaluate the Safety,Tolerability and PK of ZYT1, Following Oral Administration in Healthy Volunteers

NCT01543269 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

24

Enrollment

INDUSTRY

Sponsor class

Stopped Safety concerns

Conditions

Obesity
Lipid Disorders

Interventions

DRUG: ZYT1
DRUG: Placebo tablets

Sponsor

Zydus Lifesciences Limited